Literature DB >> 22525428

Loss of microRNA-205 expression is associated with melanoma progression.

Shujing Liu1, Michael T Tetzlaff, Aihua Liu, Bernadette Liegl-Atzwanger, Jun Guo, Xiaowei Xu.   

Abstract

In this study, we used formalin-fixed paraffin-embedded melanocytic tumors to demonstrate reproducible alterations in microRNA expression in nevi compared with melanomas using a microarray platform. We validated those results in an independent set of nevi and melanomas by quantitative RT-PCR. miR-205 demonstrated a statistically significant, progressive diminution in expression from nevi to primary melanomas to metastatic melanomas. Enforced miR-205 expression in melanoma cells profoundly impairs cell motility and migration along with significantly decreased F-actin polymerization with only a modest reduction in cell proliferation. Using a xenograft model, melanoma cells overexpressing miR-205 exhibit a reduced migratory capacity compared with control tumor cells. Mechanistically, miR-205 overexpression results in decreased expression of the zinc-finger E-box binding homeobox 2 (ZEB2) mRNA and protein. This coincides with increased expression of E-cadherin mRNA and protein. Furthermore, re-introduction of ZEB2 into melanoma cells overexpressing miR-205 rescues these phenotypic effects and results in a restoration of cell migration and F-actin polymerization with a concomitant reduction in E-cadherin expression. Together, these results provide in vitro and in vivo evidence for miR-205 as a critical suppressor of melanoma cell migration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22525428     DOI: 10.1038/labinvest.2012.62

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  34 in total

1.  Distribution of miRNA expression across human tissues.

Authors:  Nicole Ludwig; Petra Leidinger; Kurt Becker; Christina Backes; Tobias Fehlmann; Christian Pallasch; Steffi Rheinheimer; Benjamin Meder; Cord Stähler; Eckart Meese; Andreas Keller
Journal:  Nucleic Acids Res       Date:  2016-02-25       Impact factor: 16.971

Review 2.  Epigenetic markers in melanoma.

Authors:  Weimin Guo; Ting Xu; Jonathan J Lee; George F Murphy; Christine G Lian
Journal:  Melanoma Manag       Date:  2015-11-24

3.  mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.

Authors:  William Damsky; Goran Micevic; Katrina Meeth; Viswanathan Muthusamy; David P Curley; Manjula Santhanakrishnan; Ildiko Erdelyi; James T Platt; Laura Huang; Nicholas Theodosakis; M Raza Zaidi; Scott Tighe; Michael A Davies; David Dankort; Martin McMahon; Glenn Merlino; Nabeel Bardeesy; Marcus Bosenberg
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

4.  miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α.

Authors:  Jianda Zhou; Dan Xu; Huiqing Xie; Jingtian Tang; Rui Liu; Jingjing Li; Shaohua Wang; Xiang Chen; Juan Su; Xiao Zhou; Kun Xia; Quanyong He; Jia Chen; Wei Xiong; Peiguo Cao; Ke Cao
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Cancer stem cell vaccine expressing ESAT-6-gpi and IL-21 inhibits melanoma growth and metastases.

Authors:  Fengshu Zhao; Xiangfeng He; Jianan Sun; Di Wu; Meng Pan; Miao Li; Songyan Wu; Rong Zhang; Chunguang Yan; Jun Dou
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

6.  Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo.

Authors:  Shunsuke Noguchi; Junya Iwasaki; Minami Kumazaki; Takashi Mori; Kohji Maruo; Hiroki Sakai; Nami Yamada; Kazuyuki Shimada; Tomoki Naoe; Yukio Kitade; Yukihiro Akao
Journal:  Mol Ther       Date:  2013-04-30       Impact factor: 11.454

7.  microRNA-10b is a prognostic biomarker for melanoma.

Authors:  Gerald Saldanha; Shona Elshaw; Parysatis Sachs; Hisham Alharbi; Prashant Shah; Ann Jothi; J Howard Pringle
Journal:  Mod Pathol       Date:  2016-01-08       Impact factor: 7.842

8.  MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells.

Authors:  Jae-Sung Kim; Sun-Kyoung Yu; Myoung-Hwa Lee; Min-Gyeong Park; Euteum Park; Su-Gwan Kim; Sook-Young Lee; Chun Sung Kim; Heung-Joong Kim; Hong Sung Chun; Sang-Woo Chun; Do Kyung Kim
Journal:  Mol Cells       Date:  2012-12-03       Impact factor: 5.034

9.  Decreasing lncRNA HOTAIR expression inhibits human colorectal cancer stem cells.

Authors:  Jun Dou; Yaoyao Ni; Xiangfeng He; Di Wu; Miao Li; Songyan Wu; Rong Zhang; Mei Guo; Fengsu Zhao
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

10.  miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.

Authors:  Shujing Liu; Michael T Tetzlaff; Rutao Cui; Xiaowei Xu
Journal:  Am J Pathol       Date:  2012-09-13       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.